C-27-carboxylated oleanane triterpenoids up-regulate TRAIL DISC assembly via p38 MAPK and CHOP-mediated DR5
Hee Sun Byun1, Wei Zhou2, InWha Park3
1Department of Pharmacology, College of Medicine, Chungnam National University, 266 Munhwa-ro, Daejeon 35015, Republic of Korea.
Abstract:
Despite recent tremendous progress, targeting of TNF-related apoptosis-inducing ligand (TRAIL) as a cancer therapy has limited success in many clinical trials, in part due to inactivation of death inducing signaling complex (DISC)-mediated caspase-8 signaling cascade in highly malignant tumors such as glioblastoma. In this study, screening of constituents derived from Astilbe rivularis for TRAIL-sensitizing activity identified C-27-carboxylated oleanolic acid derivatives (C27OAs) including 3β-hydroxyolean-12-en-27-oic acid (C27OA-1), 3β,6β,7α-trihydroxyolean-12-en-27-oic acid (C27OA-2), and 3β-trans-p-coumaroyloxy-olean-12-en-27-oic acid (C27OA-3) as novel TRAIL sensitizers. Interestingly, these C27OAs did not affect apoptotic cell death induced by either ligation of other death receptor (DR) types, such as TNF and Fas or DNA damaging agents, which suggests that C27OAs effectively and selectively sensitize TRAIL-mediated caspase-8 activation. Mechanistically, C27OAs upregulate the expression of cell surface DR5 and DISC formation without affecting downstream intracellular apoptosis-related proteins. The upregulation of DR5 expression by C27OAs strictly depends on transactivation of C/EBP homology protein, which is regulated through the p38 MAPK pathway, rather than p53 and intracellular reactive oxygen species status. Taken together, our results identify the novel C27OAs as TRAIL sensitizers targeting the upstream DISC assembly of DR5, and provide a rationale for further development of C27OAs for facilitating TRAIL-based chemotherapy in glioblastoma patients.
Insights
Novel C-27-carboxylated oleanolic acid derivatives (C27OAs) from Astilbe rivularis enhance TRAIL-induced apoptosis. These compounds selectively sensitize glioblastoma cells by upregulating death receptor 5 (DR5) and DISC formation, offering a new strategy for cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Targeting TNF-related apoptosis-inducing ligand (TRAIL) for cancer therapy faces challenges, particularly in glioblastoma, due to impaired death-inducing signaling complex (DISC)-mediated caspase-8 activation.
- Existing treatments often struggle with resistance mechanisms in highly malignant tumors.
Purpose of the Study:
- To identify novel compounds that can sensitize cancer cells to TRAIL-induced apoptosis.
- To elucidate the mechanism by which these sensitizers function, focusing on glioblastoma.
Main Methods:
- Screening of Astilbe rivularis constituents for TRAIL-sensitizing activity.
- Investigating the effects of identified compounds on cell surface death receptor expression and DISC formation.
- Analyzing the molecular pathways involved in the sensitization process, including MAPK and transcription factor activation.
Main Results:
- C-27-carboxylated oleanolic acid derivatives (C27OAs) were identified as potent TRAIL sensitizers.
- C27OAs selectively enhanced TRAIL-mediated apoptosis by upregulating death receptor 5 (DR5) and promoting DISC assembly.
- The mechanism involves p38 MAPK pathway-dependent transactivation of C/EBP homology protein, independent of p53 or intracellular reactive oxygen species.
Conclusions:
- C27OAs represent a novel class of TRAIL sensitizers that target the upstream DISC assembly.
- These compounds offer a promising therapeutic strategy for overcoming TRAIL resistance in glioblastoma.
- Further development of C27OAs could facilitate TRAIL-based chemotherapy for glioblastoma patients.
Related Concept Videos
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps
Cell Specific Gene Expression
Regulation of Expression at Multiple Steps
Constitutive and Regulated Gene Expression
MAPK Signaling Cascades


